Emerging Growth Conference

event

Last mentioned: Feb 26, 2026

Timeline

  1. QLE Spin-off Completion

    Formal separation of the Quantum Leap Energy subsidiary into a standalone entity.

  2. Commercial Ramp-up

    Full-scale commercial production across medical and industrial isotope lines.

  3. Silicon-28 Shipments

    Initial shipments of high-purity Silicon-28 to semiconductor partners.

Stories mentioning Emerging Growth Conference 1

pharma Bullish

ASP Isotopes Targets 2026 Commercial Pivot with Silicon-28 and QLE Spin-Off

ASP Isotopes CEO Paul Mann announced a 2026 commercialization ramp-up, highlighted by the upcoming shipment of Silicon-28 and the strategic spin-off of its Quantum Leap Energy (QLE) subsidiary. The move signals a transition from a pre-commercial advanced materials firm to a revenue-generating producer of medical and industrial isotopes.

2 sources